Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1 - PubMed (original) (raw)
Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1
B Rijcken et al. Am J Respir Crit Care Med. 1995 May.
Abstract
An increased level of airway responsiveness has been proposed as a risk factor associated with the onset and prognosis of chronic airway obstruction. To determine this, longitudinal studies are necessary, with measurement of both the level of airway responsiveness and of additional risk factors, such as cigarette smoking, made before measurement of pulmonary function decline. The association of airways responsiveness with decline in FEV1 has been prospectively studied in a random sample of the Dutch population. Longitudinal data from 921 males, providing 2,376 paired observations, and 698 females, providing 1,682 paired observations, were used for analysis. Differences between responders and nonresponders (PC10 < or = 16 mg/ml of histamine) were estimated from linear regression analyses stratified by gender and smoking status, with adjustment for age, residential area, the presence of respiratory symptoms, indicators for each interval, and residuals of FEV1 at the beginning of the interval. Responders had a greater mean yearly decline in FEV1, and the differences between responders and nonresponders were similar for all gender and smoking subgroups. In an overall regression model, subjects with airway hyperresponsiveness had a significantly steeper decline in FEV1, independent of the other variables (males: beta = -12.5 ml/yr, SEM = 3.22, p < 0.001; females: beta = -11.50 ml/yr, SEM = 2.98, p < 0.001). The current analyses conclusively demonstrated that increased airway responsiveness is an independent risk factor for an accelerated decline in FEV1 and, hence, for the development of chronic obstructive lung disease. The mechanisms by which increased airway responsiveness leads to an accelerated decline in FEV, are imperfectly understood and require further study.
Similar articles
- Factors associated with bronchial responsiveness to histamine in a population sample of adults.
Rijcken B, Schouten JP, Mensinga TT, Weiss ST, De Vries K, Van der Lende R. Rijcken B, et al. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1447-53. doi: 10.1164/ajrccm/147.6_Pt_1.1447. Am Rev Respir Dis. 1993. PMID: 8503555 - The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample.
Rijcken B, Schouten JP, Weiss ST, Speizer FE, van der Lende R. Rijcken B, et al. Am Rev Respir Dis. 1988 Apr;137(4):826-32. doi: 10.1164/ajrccm/137.4.826. Am Rev Respir Dis. 1988. PMID: 3354988 - Bronchial responsiveness and five-year FEV1 decline: a study in miners and nonminers.
Hodgins P, Henneberger PK, Wang ML, Petsonk EL. Hodgins P, et al. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1390-6. doi: 10.1164/ajrccm.157.5.9701123. Am J Respir Crit Care Med. 1998. PMID: 9603113 - Longitudinal analyses of airway responsiveness and pulmonary function decline.
Rijcken B, Weiss ST. Rijcken B, et al. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S246-9. doi: 10.1164/ajrccm/154.6_Pt_2.S246. Am J Respir Crit Care Med. 1996. PMID: 8970396 Review. No abstract available. - The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease.
O'Connor GT, Sparrow D, Weiss ST. O'Connor GT, et al. Am Rev Respir Dis. 1989 Jul;140(1):225-52. doi: 10.1164/ajrccm/140.1.225. Am Rev Respir Dis. 1989. PMID: 2665587 Review.
Cited by
- Uncontrolled asthma from childhood to young adulthood associates with airflow obstruction.
Mogensen I, Hallberg J, Ekström S, Bergström A, Melén E, Kull I. Mogensen I, et al. ERJ Open Res. 2021 Oct 18;7(4):00179-2021. doi: 10.1183/23120541.00179-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34671665 Free PMC article. - Lung Function Decline in Adult Asthmatics-A 10-Year Follow-Up Retrospective and Prospective Study.
Bucchieri S, Alfano P, Audino P, Cibella F, Fazio G, Marcantonio S, Cuttitta G. Bucchieri S, et al. Diagnostics (Basel). 2021 Sep 7;11(9):1637. doi: 10.3390/diagnostics11091637. Diagnostics (Basel). 2021. PMID: 34573977 Free PMC article. - Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study.
Marcon A, Locatelli F, Keidel D, Beckmeyer-Borowko AB, Cerveri I, Dharmage SC, Fuertes E, Garcia-Aymerich J, Heinrich J, Imboden M, Janson C, Johannessen A, Leynaert B, Pascual Erquicia S, Pesce G, Schaffner E, Svanes C, Urrutia I, Jarvis D, Probst-Hensch NM, Accordini S; Ageing Lungs in European Cohorts (ALEC) study. Marcon A, et al. Thorax. 2018 Sep;73(9):825-832. doi: 10.1136/thoraxjnl-2017-211289. Epub 2018 May 2. Thorax. 2018. PMID: 29720562 Free PMC article. - Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
Jacobson GA, Raidal S, Hostrup M, Calzetta L, Wood-Baker R, Farber MO, Page CP, Walters EH. Jacobson GA, et al. Drug Saf. 2018 May;41(5):441-449. doi: 10.1007/s40264-017-0631-1. Drug Saf. 2018. PMID: 29332144 Review. - Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.
Antuni JD, Barnes PJ. Antuni JD, et al. Chronic Obstr Pulm Dis. 2016 Jun 28;3(3):653-667. doi: 10.15326/jcopdf.3.3.2016.0129. Chronic Obstr Pulm Dis. 2016. PMID: 28848890 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources